RenovoRx (RNXT) Assets (2020 - 2026)

RenovoRx has disclosed Assets across 7 years of filings, most recently posting $11.5 million for Q2 2026.

• In Q2 2026, Assets fell 15.91% year-over-year to $11.5 million; the TTM figure through Jun 2026 stood at $11.5 million (down 15.91% YoY), while the FY2025 annual figure was $8.1 million, changed 0.28% from the prior year.
• Assets came in at $11.5 million for Q2 2026 at RenovoRx, down from $14.0 million in the prior quarter.
• In the past five years, Assets ranged from a high of $16.0 million in Q1 2025 to a low of $1.5 million in Q4 2023.
• Average Assets over 5 years is $9.3 million, with a median of $9.6 million recorded in 2022.
• Year-over-year, Assets plunged 79.82% in 2023 and soared 453.75% in 2024.
• Over 5 years, Assets stood at $7.3 million in 2022, then sank by 79.82% to $1.5 million in 2023, then soared by 453.75% to $8.1 million in 2024, then slipped by 0.28% to $8.1 million in 2025, then surged by 41.72% to $11.5 million in 2026.
• Per Business Quant data, the three most recent Assets figures were $11.5 million in Q2 2026, $14.0 million in Q1 2026, and $8.1 million in Q4 2025.